Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Specimen Handling 6fludarabine 5Whole-Body Irradiation 5Cytarabine 5Cyclophosphamide 5venetoclax 4Methotrexate 4Biopsy 4merphos 3fludarabine phosphate 3blinatumomab 3N,N-dicyclohexyl-isoborneol-10-sulfonamide 3Idarubicin 3Granulocyte Colony-Stimulating Factor 3prednylidene 2deltacortene 2calaspargase pegol 2Thiotepa 2Tacrolimus 2Stem Cell Transplantation 2Spinal Puncture 2Rituximab 2Prednisone 2Mycophenolic Acid 2Magnetic Resonance Spectroscopy 2Leucovorin 2Filgrastim 2CT-P10 2Busulfan 2Asparaginase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Biphenotypic, Acute × Cord Blood Stem Cell Transplantation × 30 days × Clear all
NCT02727803 2026-05-22

Personalized NK Cell Therapy in CBT

M.D. Anderson Cancer Center

Phase 2 Recruiting
100 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡